Reference
Fremd C, et al. Mismatch repair deficiency drives durable complete remission by targeting programmed death receptor 1 in a metastatic luminal breast cancer patient. Breast Care 14: 53-59, No. 1, Mar 2019. Available from: URL: http://doi.org/10.1159/000492580 - Germany
Rights and permissions
About this article
Cite this article
Antineoplastics/epirubicin. Reactions Weekly 1747, 40 (2019). https://doi.org/10.1007/s40278-019-59681-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-59681-z